DESOXIMETASONE

DESOXIMETASONE was reported 19275 times

DESOXIMETASONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5515 0.7690
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 503 0.7530
2 SWOLLEN JOINT COUNT INCREASED 2284 0.7155
3 RHEUMATIC FEVER 3179 0.7125
4 DUODENAL ULCER PERFORATION 5038 0.6768
5 DEEP VEIN THROMBOSIS POSTOPERATIVE 1347 0.6725
6 PEMPHIGUS 8111 0.6481
7 LUPUS VULGARIS 799 0.6341
8 C-REACTIVE PROTEIN 580 0.6257
9 GRIP STRENGTH 136 0.5939
10 RHEUMATOID FACTOR POSITIVE 3410 0.5898
11 FACET JOINT SYNDROME 1834 0.5627
12 HAND DEFORMITY 7164 0.5457
13 HEPATIC ENZYME 78 0.5235
14 SWOLLEN JOINT COUNT 127 0.5080
15 HELICOBACTER INFECTION 4990 0.4850
16 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 990 0.4773
17 X-RAY ABNORMAL 782 0.4369
18 DISLOCATION OF VERTEBRA 984 0.4310
19 MUSCLE INJURY 3455 0.4166
20 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2553 0.3927
21 RETINITIS 661 0.3823
22 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 211 0.3761
23 FOLLICULITIS 3948 0.3761
24 SYNOVITIS 6683 0.3703
25 PERICARDITIS 6090 0.3621
26 ANTICIPATORY ANXIETY 98 0.3603
27 GLOSSODYNIA 7884 0.3518
28 PAIN ASSESSMENT 10 0.3226
29 PERIPHERAL VENOUS DISEASE 1309 0.3202
30 C-REACTIVE PROTEIN ABNORMAL 1951 0.3038
31 SERONEGATIVE ARTHRITIS 340 0.2967
32 HYPOCHOLESTEROLAEMIA 88 0.2493
33 WOUND 6725 0.2404
34 SYSTEMIC LUPUS ERYTHEMATOSUS 8376 0.2358
35 BREAST CANCER STAGE III 1487 0.2294
36 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 24 0.2286
37 BONE EROSION 805 0.2274
38 CONTRAINDICATED PRODUCT ADMINISTERED 6210 0.2049
39 LIP DRY 1788 0.1967
40 PORPHYRIA ACUTE 267 0.1861
41 DRUG TOLERANCE DECREASED 522 0.1857
42 ONYCHOMADESIS 770 0.1833
43 IRRITABLE BOWEL SYNDROME 3769 0.1756
44 GRIP STRENGTH DECREASED 1537 0.1745
45 ACQUIRED PORPHYRIA 12 0.1690
46 HYPERCHOLESTEROLAEMIA 1596 0.1651
47 JOINT RANGE OF MOTION DECREASED 2210 0.1646
48 OVERLAP SYNDROME 115 0.1643
49 CRYOPYRIN ASSOCIATED PERIODIC SYNDROME 32 0.1633
50 LIVE BIRTH 1339 0.1599
51 ANKLE DEFORMITY 51 0.1589
52 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 362 0.1570
53 ANKLE ARTHROPLASTY 56 0.1543
54 WOUND INFECTION 1681 0.1533
55 BLEPHAROSPASM 963 0.1528
56 MESENTERITIS 23 0.1523
57 BURSITIS 1757 0.1447
58 PROSTHESIS USER 13 0.1444
59 TENDER JOINT COUNT 12 0.1429
60 NAIL OPERATION 58 0.1401
61 FIBROMYALGIA 3335 0.1370
62 AUTOIMMUNE DISORDER 1326 0.1359
63 JOINT DESTRUCTION 209 0.1343
64 RED BLOOD CELL SEDIMENTATION RATE 37 0.1326
65 JOINT ANKYLOSIS 75 0.1320
66 ONYCHOMYCOSIS 566 0.1289
67 ARTHROPATHY 6983 0.1255
68 AORTIC BRUIT 12 0.1250
69 LIVER INJURY 3055 0.1243
70 IMPAIRED HEALING 3983 0.1212
71 STEROID DEPENDENCE 105 0.1196
72 DEATH NEONATAL 164 0.1178
73 CATARRH 102 0.1128
74 PALATE INJURY 9 0.1084
75 TYPE 2 DIABETES MELLITUS 3646 0.1082
76 MUSCULOSKELETAL DEFORMITY 25 0.1068
77 FINGER DEFORMITY 503 0.1037
78 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 78 0.0977
79 PSORIATIC ARTHROPATHY 3963 0.0975
80 NAIL DISORDER 852 0.0973
81 CARCINOID TUMOUR OF THE SMALL BOWEL 10 0.0962
82 MATERNAL EXPOSURE TIMING UNSPECIFIED 355 0.0944
83 SUTURE REMOVAL 10 0.0935
84 INFUSION RELATED REACTION 6190 0.0933
85 DISCOMFORT 5695 0.0932
86 OBESITY 1469 0.0921
87 BONE CYST 86 0.0917
88 URTICARIA THERMAL 13 0.0915
89 THERAPEUTIC PRODUCT EFFECT DECREASED 4086 0.0911
90 ADRENAL CYST 10 0.0909
91 INFUSION SITE REACTION 271 0.0906
92 HIP ARTHROPLASTY 1355 0.0884
93 SCIATICA 1382 0.0866
94 BACTERIAL VULVOVAGINITIS 25 0.0865
95 HEPATIC ENZYME INCREASED 5762 0.0844
96 RED BLOOD CELL SEDIMENTATION RATE INCREASED 932 0.0841
97 EXOSTOSIS 751 0.0822
98 FOOT DEFORMITY 892 0.0804
99 CALCIFICATION OF MUSCLE 10 0.0800
100 SWELLING 7357 0.0785
101 DISABILITY ASSESSMENT SCALE SCORE INCREASED 24 0.0782
102 LOWER RESPIRATORY TRACT INFECTION 3503 0.0769
103 SOFT TISSUE DISORDER 85 0.0766
104 PULMONARY FIBROSIS 1451 0.0756
105 WALKING AID USER 494 0.0748
106 BLISTER 4187 0.0745
107 RHEUMATOID ARTHRITIS 8445 0.0743
108 LUPUS-LIKE SYNDROME 671 0.0739
109 BLOOD CHOLESTEROL INCREASED 3394 0.0727
110 DRUG INTOLERANCE 6872 0.0711
111 BUNION OPERATION 39 0.0695
112 PRODUCT LABEL CONFUSION 403 0.0691
113 LOWER LIMB FRACTURE 1326 0.0689
114 PRESCRIBED OVERDOSE 1327 0.0685
115 SOFT TISSUE SWELLING 38 0.0669
116 TRANSFUSION-RELATED CIRCULATORY OVERLOAD 16 0.0661
117 BURNS SECOND DEGREE 115 0.0655
118 KNEE ARTHROPLASTY 1352 0.0642
119 STOMATITIS 3802 0.0626
120 PUSTULAR PSORIASIS 213 0.0620
121 JOINT DISLOCATION 653 0.0617
122 PARAESTHESIA EAR 9 0.0612
123 MATERNAL EXPOSURE DURING PREGNANCY 5400 0.0605
124 LOOSE BODY IN JOINT 16 0.0602
125 BACK INJURY 642 0.0590
126 EYE INJURY 179 0.0589
127 GAIT INABILITY 1954 0.0584
128 BLOOD FOLATE DECREASED 42 0.0578
129 COELIAC DISEASE 562 0.0572
130 SPONDYLITIS 202 0.0555
131 BREAST CANCER STAGE II 455 0.0546
132 JOINT SWELLING 6590 0.0545
133 CONGENITAL ANOMALY 420 0.0542
134 BLOOD IMMUNOGLOBULIN M INCREASED 32 0.0526
135 TREATMENT FAILURE 4358 0.0525
136 DRUG TOLERANCE 263 0.0519
137 ULCER HAEMORRHAGE 351 0.0518
138 PRESCRIBED UNDERDOSE 1023 0.0512
139 ARTHRODESIS 52 0.0511
140 BLOOD IMMUNOGLOBULIN A DECREASED 32 0.0492
141 ILL-DEFINED DISORDER 2985 0.0491
142 ANAL FISSURE HAEMORRHAGE 9 0.0489
143 OSTEOARTHRITIS 2073 0.0488
144 NIGHT SWEATS 1574 0.0488
145 TRANSAMINASES ABNORMAL 28 0.0481
146 MYCOTIC ALLERGY 41 0.0480
147 ABDOMINAL DISCOMFORT 8037 0.0479
148 FALLOPIAN TUBE DISORDER 14 0.0475
149 C-REACTIVE PROTEIN INCREASED 1725 0.0474
150 ANTIPHOSPHOLIPID ANTIBODIES 9 0.0462
151 MOBILITY DECREASED 3313 0.0461
152 ADMINISTRATION SITE ERYTHEMA 13 0.0456
153 WRIST DEFORMITY 27 0.0439
154 TASTE DISORDER 891 0.0439
155 SPONDYLOARTHROPATHY 26 0.0433
156 SELF-CONSCIOUSNESS 11 0.0433
157 INJURY 3021 0.0429
158 MEAN PLATELET VOLUME DECREASED 36 0.0429
159 ALOPECIA 8417 0.0428
160 RHEUMATOID NODULE 118 0.0428
161 WHEEZING 2523 0.0425
162 HEPATIC CIRRHOSIS 796 0.0423
163 MUSCULOSKELETAL STIFFNESS 3656 0.0417
164 RASH VESICULAR 198 0.0409
165 INFLAMMATION 2089 0.0404
166 JOINT SPACE NARROWING 12 0.0403
167 FUNGAL PHARYNGITIS 10 0.0398
168 BACILLUS INFECTION 25 0.0396
169 BLOOD PRESSURE DIASTOLIC ABNORMAL 98 0.0385
170 LIVER FUNCTION TEST INCREASED 822 0.0382
171 PNEUMONIA VIRAL 122 0.0382
172 POLYARTHRITIS 200 0.0379
173 CENTRAL OBESITY 28 0.0379
174 GENERAL PHYSICAL HEALTH DETERIORATION 4364 0.0377
175 SPINAL FUSION SURGERY 153 0.0377
176 INTENTIONAL PRODUCT USE ISSUE 3277 0.0374
177 ALANINE AMINOTRANSFERASE ABNORMAL 78 0.0369
178 NORMAL NEWBORN 198 0.0364
179 ALCOHOL POISONING 97 0.0362
180 LUNG DISORDER 1759 0.0359
181 EPILEPSY 1097 0.0359
182 GASTROINTESTINAL DISORDER 3194 0.0356
183 OEDEMA 1916 0.0353
184 ROAD TRAFFIC ACCIDENT 1429 0.0341
185 CENTRAL PAIN SYNDROME 9 0.0340
186 PREGNANCY 676 0.0337
187 SLEEP DISORDER 2378 0.0337
188 LIVER DISORDER 1489 0.0335
189 THYMOMA 12 0.0332
190 JOINT LAXITY 10 0.0331
191 BLOOD IMMUNOGLOBULIN G INCREASED 40 0.0329
192 HYPERSENSITIVITY 6041 0.0325
193 EXPOSURE DURING PREGNANCY 1982 0.0319
194 OSTEOLYSIS 65 0.0318
195 DRUG-INDUCED LIVER INJURY 990 0.0315
196 SINUSITIS 3218 0.0314
197 MUSCULOSKELETAL PAIN 1639 0.0313
198 VASCULAR ACCESS COMPLICATION 25 0.0309
199 NERVE BLOCK 18 0.0308
200 CONTUSION 2966 0.0308
201 DELIRIUM 1050 0.0302
202 ALLERGY TO ANIMAL 32 0.0300
203 HYPOPNOEA 102 0.0294
204 JOINT STIFFNESS 750 0.0286
205 EXPOSURE TO ALLERGEN 9 0.0282
206 CHONDROCALCINOSIS 18 0.0276
207 IODINE ALLERGY 9 0.0270
208 GRANULOMA SKIN 22 0.0268
209 INFECTION 3876 0.0268
210 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 455 0.0265
211 PERFORATION 21 0.0261
212 EPISCLERITIS 18 0.0260
213 THERAPY NON-RESPONDER 1165 0.0259
214 PERIPHERAL SWELLING 3931 0.0255
215 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1209 0.0251
216 DRY MOUTH 2037 0.0251
217 BLOOD PRESSURE SYSTOLIC ABNORMAL 62 0.0251
218 ADVERSE REACTION 331 0.0249
219 PHARYNGEAL PARAESTHESIA 39 0.0246
220 EAR INFECTION 651 0.0244
221 CONFUSIONAL STATE 3908 0.0242
222 HEPATITIS 618 0.0241
223 PRODUCT USE ISSUE 4535 0.0241
224 BURSITIS INFECTIVE 13 0.0239
225 GENERAL SYMPTOM 178 0.0237
226 HERPES ZOSTER OTICUS 12 0.0237
227 DISABILITY 468 0.0236
228 MYOSITIS 210 0.0234
229 BLOOD CHOLESTEROL 11 0.0232
230 SHOULDER ARTHROPLASTY 61 0.0226
231 DRUG USE DISORDER 189 0.0225
232 ENTHESOPATHY 35 0.0224
233 RHEUMATIC DISORDER 43 0.0222
234 NASOPHARYNGITIS 4012 0.0217
235 LOWER RESPIRATORY TRACT CONGESTION 37 0.0217
236 HYPOAESTHESIA 3231 0.0216
237 BONE GRAFT 20 0.0214
238 EAR PAIN 416 0.0214
239 FOOT OPERATION 103 0.0208
240 CHALAZION 13 0.0203
241 THYROXINE DECREASED 12 0.0194
242 ELBOW OPERATION 12 0.0193
243 WRIST SURGERY 18 0.0193
244 MIGRAINE 1833 0.0192
245 FRACTURE DELAYED UNION 16 0.0189
246 DYSPEPSIA 1790 0.0182
247 HYPERTENSION 3840 0.0181
248 BRONCHIECTASIS 121 0.0179
249 WEIGHT INCREASED 4019 0.0179
250 OSTEOPOROSIS 733 0.0178
251 ADRENAL INSUFFICIENCY 216 0.0178
252 INTERVERTEBRAL DISC SPACE NARROWING 14 0.0174
253 FREQUENT BOWEL MOVEMENTS 467 0.0173
254 ARTHRITIS 1359 0.0173
255 PRURITUS ALLERGIC 20 0.0171
256 BODY TEMPERATURE DECREASED 168 0.0170
257 HEPATIC ENZYME ABNORMAL 85 0.0170
258 RESPIRATORY DISORDER 508 0.0170
259 CONDITION AGGRAVATED 5136 0.0169
260 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 285 0.0168
261 BLOOD PRESSURE DIASTOLIC DECREASED 123 0.0166
262 BLOODY DISCHARGE 19 0.0166
263 URTICARIA 2755 0.0164
264 IMMUNODEFICIENCY 243 0.0163
265 RASH 7093 0.0163
266 MEAN CELL VOLUME DECREASED 25 0.0162
267 NAIL DYSTROPHY 9 0.0161
268 BLADDER TRANSITIONAL CELL CARCINOMA 23 0.0161
269 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1142 0.0160
270 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 38 0.0160
271 ONYCHOCLASIS 110 0.0160
272 LABYRINTHITIS 40 0.0158
273 FOREARM FRACTURE 11 0.0158
274 PAROSMIA 118 0.0156
275 ARTHRALGIA 6434 0.0155
276 STEROID DIABETES 23 0.0153
277 DACTYLITIS 15 0.0153
278 FEAR OF DISEASE 27 0.0152
279 AMNESIA 981 0.0151
280 ADVERSE EVENT 1386 0.0150
281 BLOOD PRESSURE DIASTOLIC INCREASED 69 0.0149
282 NECK PAIN 834 0.0149
283 OTORRHOEA 26 0.0149
284 PAIN 9143 0.0149
285 BLOOD PARATHYROID HORMONE DECREASED 22 0.0148
286 RHINITIS 119 0.0147
287 RHEUMATOID LUNG 14 0.0147
288 WEIGHT FLUCTUATION 153 0.0146
289 NASAL DISCHARGE DISCOLOURATION 20 0.0145
290 MEAN CELL HAEMOGLOBIN DECREASED 26 0.0142
291 JOINT ARTHROPLASTY 25 0.0140
292 GINGIVAL PAIN 111 0.0139
293 SUSPECTED OFF LABEL USE 63 0.0139
294 ADVERSE DRUG REACTION 1248 0.0139
295 ABDOMINAL LYMPHADENOPATHY 12 0.0138
296 BLOOD PRESSURE SYSTOLIC INCREASED 269 0.0138
297 MEDICATION ERROR 757 0.0136
298 ASTHMA 1537 0.0136
299 GASTROOESOPHAGEAL REFLUX DISEASE 1073 0.0133
300 CARDIAC MURMUR 113 0.0130
301 ABDOMINAL PAIN UPPER 2655 0.0129
302 BLISTER INFECTED 10 0.0128
303 TENOSYNOVITIS 35 0.0127
304 MUSCULAR WEAKNESS 1433 0.0126
305 NODULE 164 0.0126
306 BRONCHIAL WALL THICKENING 9 0.0125
307 BITE 9 0.0124
308 WHEELCHAIR USER 55 0.0124
309 LIMB MASS 27 0.0123
310 MEMORY IMPAIRMENT 1678 0.0122
311 COLITIS MICROSCOPIC 56 0.0118
312 COLITIS ULCERATIVE 523 0.0117
313 FATIGUE 9090 0.0117
314 BACK DISORDER 189 0.0116
315 BONE LESION 41 0.0114
316 NERVE INJURY 124 0.0111
317 RECTAL ULCER 13 0.0111
318 CUSHINGOID 35 0.0109
319 PARAESTHESIA 1713 0.0109
320 RESPIRATORY TRACT CONGESTION 171 0.0108
321 LIMB DEFORMITY 17 0.0107
322 SKIN PLAQUE 90 0.0107
323 MONOCYTE COUNT DECREASED 13 0.0106
324 ANAL FISSURE 57 0.0106
325 SACROILIITIS 20 0.0106
326 SKIN INJURY 35 0.0105
327 PYREXIA 3626 0.0105
328 NASAL INFLAMMATION 11 0.0104
329 UPPER RESPIRATORY TRACT INFECTION 480 0.0104
330 BLOOD PRESSURE FLUCTUATION 247 0.0103
331 TONGUE HAEMORRHAGE 12 0.0102
332 MUSCLE SPASTICITY 124 0.0101
333 HEPATIC FIBROSIS 34 0.0099
334 LYMPHOMA 152 0.0098
335 DECREASED APPETITE 2273 0.0098
336 RECTAL HAEMORRHAGE 419 0.0097
337 MENOPAUSE 25 0.0097
338 BREAST DISCOMFORT 10 0.0097
339 PRODUCT USE IN UNAPPROVED INDICATION 2396 0.0097
340 INJECTION SITE REACTION 665 0.0097
341 ANAL ABSCESS 52 0.0096
342 GASTROINTESTINAL BACTERIAL INFECTION 11 0.0096
343 CHEST PAIN 1778 0.0096
344 CORNEAL ABRASION 13 0.0095
345 OEDEMA PERIPHERAL 1156 0.0095
346 TONGUE OEDEMA 36 0.0094
347 PAIN IN EXTREMITY 2714 0.0092
348 HYPERTRANSAMINASAEMIA 64 0.0092
349 UPPER RESPIRATORY TRACT INFLAMMATION 11 0.0092
350 JOINT INJURY 196 0.0092
351 PANNICULITIS 22 0.0091
352 PRURITUS 3494 0.0091
353 INVESTIGATION ABNORMAL 13 0.0090
354 BLOOD IMMUNOGLOBULIN M DECREASED 9 0.0090
355 GAIT DISTURBANCE 1695 0.0088
356 TOOTH INFECTION 116 0.0088
357 LIMB DISCOMFORT 272 0.0088
358 DRUG SPECIFIC ANTIBODY PRESENT 57 0.0088
359 INSOMNIA 2331 0.0087
360 TENDERNESS 91 0.0087
361 DEPRESSION 1962 0.0086
362 THERAPEUTIC RESPONSE DECREASED 522 0.0086
363 PULMONARY CONGESTION 113 0.0086
364 ANKYLOSING SPONDYLITIS 112 0.0085
365 MUSCLE SPASMS 1550 0.0084
366 OSTEOPOROTIC FRACTURE 16 0.0084
367 SPUTUM DISCOLOURED 79 0.0083
368 BACTERIAL VAGINOSIS 13 0.0083
369 TONGUE COATED 14 0.0081
370 UNDERDOSE 589 0.0081
371 EFFUSION 11 0.0080
372 ORAL FUNGAL INFECTION 22 0.0080
373 LIGAMENT INJURY 9 0.0079
374 BRONCHITIS 585 0.0079
375 BRONCHIAL SECRETION RETENTION 10 0.0078
376 PNEUMONIA 2541 0.0078
377 DRUG INEFFECTIVE 10104 0.0077
378 MATERNAL EXPOSURE BEFORE PREGNANCY 52 0.0076
379 DYSPNOEA AT REST 22 0.0076
380 JOINT EFFUSION 52 0.0075
381 SKIN REACTION 106 0.0075
382 IMPAIRED QUALITY OF LIFE 108 0.0075
383 PERIARTHRITIS 17 0.0075
384 INTERNATIONAL NORMALISED RATIO FLUCTUATION 15 0.0072
385 OPHTHALMIC HERPES ZOSTER 13 0.0072
386 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 12 0.0072
387 MENISCUS INJURY 43 0.0070
388 MALAISE 3064 0.0070
389 LABORATORY TEST ABNORMAL 206 0.0070
390 GASTROENTERITIS VIRAL 126 0.0070
391 VARICOSE VEIN 36 0.0070
392 MONOCYTE COUNT INCREASED 25 0.0069
393 VOMITING 3232 0.0069
394 SINUS PAIN 16 0.0069
395 OFF LABEL USE 5972 0.0068
396 PSORIASIS 888 0.0068
397 ECCHYMOSIS 46 0.0067
398 ANGIOPLASTY 10 0.0067
399 IMPAIRED WORK ABILITY 143 0.0067
400 INJECTION RELATED REACTION 11 0.0067
401 INFERTILITY 10 0.0066
402 ASTIGMATISM 10 0.0066
403 ASPARTATE AMINOTRANSFERASE ABNORMAL 10 0.0066
404 WHITE BLOOD CELL COUNT INCREASED 252 0.0066
405 BLOOD TEST ABNORMAL 92 0.0065
406 DYSPNOEA 3682 0.0065
407 ASTHENIA 2441 0.0065
408 ABDOMINAL PAIN 1486 0.0064
409 VISUAL IMPAIRMENT 790 0.0064
410 DRUG LEVEL BELOW THERAPEUTIC 35 0.0063
411 ARTHRITIS BACTERIAL 26 0.0063
412 HEPATIC STEATOSIS 118 0.0063
413 HEADACHE 3962 0.0063
414 NAIL INFECTION 9 0.0063
415 FOOD INTOLERANCE 23 0.0063
416 CALCINOSIS 14 0.0063
417 SCRATCH 66 0.0063
418 EYE DISORDER 205 0.0062
419 PULMONARY PAIN 18 0.0062
420 KIDNEY INFECTION 121 0.0062
421 GASTROINTESTINAL PAIN 67 0.0061
422 FEELING HOT 372 0.0061
423 HEART RATE DECREASED 211 0.0060
424 CONTRAINDICATED PRODUCT PRESCRIBED 10 0.0059
425 HERPES ZOSTER 342 0.0059
426 VAGINAL INFECTION 28 0.0059
427 ABDOMINAL DISTENSION 620 0.0059
428 TUBULOINTERSTITIAL NEPHRITIS 111 0.0059
429 HYPOCALCAEMIA 112 0.0059
430 DRUG LEVEL ABOVE THERAPEUTIC 27 0.0059
431 DEFORMITY 55 0.0059
432 INJECTION SITE OEDEMA 10 0.0058
433 WEIGHT DECREASED 1620 0.0058
434 CATARACT OPERATION 34 0.0057
435 SECRETION DISCHARGE 71 0.0057
436 ULCER 90 0.0057
437 PHYSICAL DISABILITY 25 0.0056
438 MULTIPLE ALLERGIES 44 0.0056
439 HUNGER 78 0.0056
440 CHRONIC SINUSITIS 21 0.0056
441 BREAST SWELLING 15 0.0056
442 DIZZINESS 2754 0.0055
443 DIARRHOEA 3558 0.0055
444 INTESTINAL POLYP 9 0.0055
445 BODY TEMPERATURE ABNORMAL 10 0.0054
446 RESPIRATORY RATE INCREASED 48 0.0054
447 PRODUCT QUALITY ISSUE 733 0.0054
448 BLOOD IMMUNOGLOBULIN E INCREASED 13 0.0054
449 PANCREATITIS 282 0.0053
450 MUCOUS STOOLS 26 0.0052
451 BODY TEMPERATURE INCREASED 107 0.0052
452 FOOT FRACTURE 99 0.0052
453 PLATELET COUNT INCREASED 68 0.0052
454 ORAL DISORDER 38 0.0052
455 BICYTOPENIA 10 0.0051
456 RED BLOOD CELL COUNT INCREASED 14 0.0051
457 INCORRECT PRODUCT ADMINISTRATION DURATION 110 0.0051
458 BREAST CANCER STAGE I 47 0.0051
459 AORTIC ARTERIOSCLEROSIS 13 0.0050
460 SINUS HEADACHE 30 0.0050
461 ANXIETY 1428 0.0050
462 TOOTH LOSS 104 0.0050
463 GLAUCOMA 96 0.0050
464 FAECES SOFT 36 0.0049
465 FORCED EXPIRATORY VOLUME DECREASED 14 0.0049
466 OXYGEN SATURATION ABNORMAL 14 0.0049
467 TACHYPHRENIA 17 0.0049
468 NASAL POLYPS 24 0.0049
469 LYMPH NODE PAIN 9 0.0048
470 BODY TEMPERATURE FLUCTUATION 10 0.0048
471 LYME DISEASE 16 0.0048
472 FLUID RETENTION 243 0.0048
473 NEPHROLITHIASIS 219 0.0048
474 PRODUCTIVE COUGH 227 0.0048
475 SENSITIVITY TO WEATHER CHANGE 25 0.0047
476 FAECAL CALPROTECTIN INCREASED 15 0.0047
477 POOR VENOUS ACCESS 49 0.0047
478 POLYMYALGIA RHEUMATICA 15 0.0047
479 CREPITATIONS 14 0.0047
480 TENDONITIS 72 0.0046
481 FOETAL EXPOSURE DURING PREGNANCY 378 0.0046
482 INJECTION SITE INFLAMMATION 23 0.0046
483 SPINAL STENOSIS 19 0.0046
484 TOOTH DISORDER 102 0.0046
485 JOINT NOISE 9 0.0046
486 MUSCULOSKELETAL DISORDER 86 0.0045
487 PHARYNGITIS 56 0.0045
488 APHTHOUS ULCER 35 0.0045
489 TACHYCARDIA 400 0.0045
490 HERNIA 87 0.0045
491 NAUSEA 3525 0.0044
492 TENDON DISORDER 29 0.0044
493 IRON DEFICIENCY 20 0.0044
494 ORAL PAIN 99 0.0044
495 HAEMATOCHEZIA 243 0.0044
496 LIVER FUNCTION TEST ABNORMAL 128 0.0044
497 ORTHOPNOEA 14 0.0044
498 SWOLLEN TONGUE 137 0.0044
499 RHINALGIA 12 0.0044
500 IMMOBILE 19 0.0043
501 ORAL INFECTION 17 0.0043
502 GRANULOMA 15 0.0043
503 LEUKOPENIA 216 0.0043
504 UVEITIS 58 0.0043
505 PULMONARY TOXICITY 30 0.0042
506 SKIN NECROSIS 22 0.0042
507 INGROWING NAIL 10 0.0042
508 SPINAL DISORDER 40 0.0042
509 HYPOKALAEMIA 194 0.0042
510 ACCIDENT 50 0.0042
511 GASTROENTERITIS 61 0.0042
512 FINE MOTOR SKILL DYSFUNCTION 12 0.0041
513 UPPER RESPIRATORY TRACT CONGESTION 12 0.0041
514 NASAL DISORDER 11 0.0041
515 GASTROINTESTINAL INFECTION 37 0.0041
516 BLOOD POTASSIUM ABNORMAL 11 0.0041
517 DRUG LEVEL DECREASED 42 0.0041
518 DANDRUFF 9 0.0041
519 ECZEMA 211 0.0040
520 UTERINE LEIOMYOMA 29 0.0040
521 MOVEMENT DISORDER 127 0.0040
522 TRIGGER FINGER 16 0.0039
523 CATARACT 232 0.0039
524 HAEMANGIOMA 9 0.0039
525 BLOOD PRESSURE INCREASED 582 0.0038
526 ACCIDENTAL OVERDOSE 139 0.0038
527 SARCOIDOSIS 18 0.0038
528 RALES 22 0.0038
529 SCAB 43 0.0038
530 THERAPEUTIC RESPONSE SHORTENED 125 0.0038
531 FLANK PAIN 35 0.0037
532 CONCOMITANT DISEASE AGGRAVATED 23 0.0037
533 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 669 0.0037
534 VITAMIN B12 DEFICIENCY 15 0.0037
535 RHINORRHOEA 238 0.0037
536 LOCALISED INFECTION 89 0.0037
537 POLYP 24 0.0037
538 BLOOD IMMUNOGLOBULIN G DECREASED 9 0.0036
539 DIVERTICULITIS 100 0.0036
540 SKIN ABRASION 17 0.0036
541 PYELONEPHRITIS 31 0.0036
542 NASAL CONGESTION 209 0.0036
543 RESPIRATORY TRACT INFECTION 92 0.0035
544 NASAL DISCOMFORT 28 0.0035
545 BEDRIDDEN 46 0.0035
546 MUSCULOSKELETAL DISCOMFORT 60 0.0035
547 NON-CARDIAC CHEST PAIN 11 0.0035
548 FURUNCLE 27 0.0034
549 PAPULE 24 0.0034
550 INFUSION SITE EXTRAVASATION 21 0.0034
551 HEART RATE IRREGULAR 76 0.0034
552 FACIAL PAIN 30 0.0034
553 CYSTITIS 107 0.0034
554 MYASTHENIA GRAVIS 27 0.0033
555 NEURALGIA 81 0.0033
556 SKIN LACERATION 36 0.0033
557 ORAL DISCOMFORT 46 0.0033
558 RASH PRURITIC 179 0.0033
559 MOUTH ULCERATION 69 0.0033
560 DUODENAL ULCER 23 0.0033
561 DECREASED ACTIVITY 35 0.0032
562 FEAR OF INJECTION 23 0.0032
563 BLOOD BLISTER 10 0.0032
564 PULMONARY FUNCTION TEST DECREASED 14 0.0032
565 ANAL FISTULA 17 0.0032
566 DERMATITIS ALLERGIC 40 0.0032
567 JOINT LOCK 9 0.0032
568 TENDON PAIN 24 0.0032
569 ESCHERICHIA INFECTION 26 0.0032
570 DECREASED IMMUNE RESPONSIVENESS 31 0.0032
571 VERTIGO 192 0.0031
572 OXYGEN SATURATION DECREASED 177 0.0031
573 EAR PRURITUS 11 0.0031
574 RED CELL DISTRIBUTION WIDTH INCREASED 13 0.0031
575 BONE DISORDER 57 0.0031
576 TENSION 19 0.0031
577 OROPHARYNGEAL PAIN 288 0.0031
578 ASPIRATION 34 0.0031
579 NIGHTMARE 107 0.0031
580 PIGMENTATION DISORDER 19 0.0031
581 ANAPHYLACTIC SHOCK 79 0.0031
582 TONGUE DISCOMFORT 13 0.0031
583 HYPERAESTHESIA 25 0.0030
584 PURULENT DISCHARGE 13 0.0030
585 ANKLE FRACTURE 46 0.0030
586 SEPTIC SHOCK 129 0.0030
587 QUALITY OF LIFE DECREASED 39 0.0029
588 ALANINE AMINOTRANSFERASE INCREASED 176 0.0029
589 TOOTH ABSCESS 29 0.0028
590 SPINAL OSTEOARTHRITIS 25 0.0028
591 ABSCESS LIMB 12 0.0028
592 ARTHRITIS INFECTIVE 13 0.0028
593 ROSACEA 13 0.0028
594 GINGIVITIS 15 0.0028
595 ANAPHYLACTIC REACTION 153 0.0028
596 HAEMORRHOIDS 54 0.0028
597 DYSPNOEA EXERTIONAL 104 0.0028
598 INJECTION SITE DISCOMFORT 29 0.0028
599 HYPOKINESIA 40 0.0028
600 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 17 0.0027
601 BACTERIAL INFECTION 51 0.0027
602 DEEP VEIN THROMBOSIS 176 0.0027
603 DYSSTASIA 79 0.0027
604 FALL 894 0.0027
605 ABSCESS 42 0.0026
606 THERAPEUTIC PRODUCT EFFECT DELAYED 12 0.0026
607 SEASONAL ALLERGY 37 0.0026
608 FUNCTIONAL GASTROINTESTINAL DISORDER 9 0.0026
609 SYNOVIAL CYST 12 0.0026
610 AUTOIMMUNE HEPATITIS 18 0.0026
611 SARS-COV-2 TEST POSITIVE 34 0.0026
612 VITAMIN D DECREASED 22 0.0026
613 VULVOVAGINAL MYCOTIC INFECTION 10 0.0025
614 TOOTHACHE 46 0.0025
615 INCREASED UPPER AIRWAY SECRETION 13 0.0025
616 HOSPITALISATION 389 0.0025
617 TONGUE DISCOLOURATION 11 0.0025
618 SYMPTOM RECURRENCE 15 0.0025
619 HYPERTHERMIA 19 0.0025
620 INTERVERTEBRAL DISC DEGENERATION 23 0.0025
621 EYE INFECTION 28 0.0025
622 INFLUENZA 276 0.0025
623 CARDIAC VALVE DISEASE 14 0.0024
624 HYPOTHYROIDISM 78 0.0024
625 DIABETES MELLITUS 186 0.0024
626 MULTIPLE FRACTURES 40 0.0024
627 PLEURAL EFFUSION 148 0.0024
628 CARPAL TUNNEL SYNDROME 34 0.0024
629 OVERWEIGHT 13 0.0024
630 TINNITUS 111 0.0024
631 ABDOMINAL HERNIA 11 0.0024
632 METABOLIC DISORDER 14 0.0024
633 SKIN DISORDER 80 0.0024
634 RENAL CYST 19 0.0024
635 DRUG ERUPTION 42 0.0024
636 GASTRIC ULCER 45 0.0024
637 BOWEL MOVEMENT IRREGULARITY 18 0.0023
638 TONGUE DISORDER 17 0.0023
639 BREAST PAIN 25 0.0023
640 CYST 29 0.0023
641 FEELING COLD 65 0.0023
642 LOSS OF CONSCIOUSNESS 298 0.0023
643 OROPHARYNGEAL DISCOMFORT 21 0.0023
644 BACK PAIN 537 0.0023
645 CELLULITIS 115 0.0023
646 BLOOD IRON DECREASED 27 0.0023
647 HEART RATE INCREASED 225 0.0023
648 THERMAL BURN 16 0.0023
649 VASCULITIS 26 0.0022
650 TREATMENT NONCOMPLIANCE 122 0.0022
651 ORAL CANDIDIASIS 29 0.0022
652 HYPERKERATOSIS 12 0.0022
653 NEOPLASM 25 0.0022
654 PSYCHOMOTOR HYPERACTIVITY 36 0.0022
655 GAMMA-GLUTAMYLTRANSFERASE INCREASED 48 0.0022
656 DYSLIPIDAEMIA 11 0.0022
657 HEPATOTOXICITY 48 0.0022
658 IMMUNOSUPPRESSION 19 0.0022
659 DEFAECATION URGENCY 15 0.0021
660 MUSCULOSKELETAL CHEST PAIN 33 0.0021
661 FAECES DISCOLOURED 46 0.0021
662 ANAL INCONTINENCE 19 0.0021
663 COUGH 589 0.0021
664 CLOSTRIDIUM DIFFICILE INFECTION 45 0.0021
665 HORMONE LEVEL ABNORMAL 10 0.0020
666 PARONYCHIA 9 0.0020
667 DERMATITIS CONTACT 23 0.0020
668 FAECALOMA 11 0.0020
669 ORAL HERPES 39 0.0020
670 BONE LOSS 30 0.0020
671 THROAT IRRITATION 89 0.0020
672 HEAD DISCOMFORT 35 0.0020
673 PALPITATIONS 231 0.0020
674 TOE AMPUTATION 10 0.0020
675 POST PROCEDURAL INFECTION 16 0.0020
676 EAR DISORDER 9 0.0020
677 NEOPLASM MALIGNANT 131 0.0020
678 ASPARTATE AMINOTRANSFERASE INCREASED 104 0.0020
679 CANDIDA INFECTION 33 0.0020
680 PHLEBITIS 10 0.0020
681 THYROID DISORDER 30 0.0019
682 CHOLELITHIASIS 62 0.0019
683 LOSS OF LIBIDO 17 0.0019
684 FEELING JITTERY 36 0.0019
685 RESPIRATION ABNORMAL 13 0.0019
686 DYSPHONIA 110 0.0019
687 SKIN INFECTION 21 0.0019
688 URINE ODOUR ABNORMAL 11 0.0019
689 ILLNESS 192 0.0019
690 HYPERCALCAEMIA 23 0.0019
691 NEUTROPHIL COUNT INCREASED 19 0.0019
692 EAR DISCOMFORT 19 0.0018
693 RIB FRACTURE 38 0.0018
694 BLOOD URINE PRESENT 35 0.0018
695 JAW DISORDER 10 0.0018
696 FEAR 49 0.0018
697 GASTRIC DISORDER 62 0.0018
698 VIRAL INFECTION 60 0.0018
699 PARAESTHESIA ORAL 26 0.0018
700 TENDON RUPTURE 22 0.0018
701 SENSATION OF FOREIGN BODY 15 0.0018
702 TRANSAMINASES INCREASED 39 0.0018
703 PERIPHERAL COLDNESS 24 0.0017
704 ERYTHEMA 357 0.0017
705 URINARY TRACT INFECTION 293 0.0017
706 OVARIAN CYST 17 0.0017
707 UPPER-AIRWAY COUGH SYNDROME 14 0.0017
708 LIPASE INCREASED 13 0.0017
709 EATING DISORDER 35 0.0016
710 FACIAL PARALYSIS 14 0.0016
711 SKIN FISSURES 32 0.0016
712 THROMBOCYTOPENIA 183 0.0016
713 COVID-19 286 0.0016
714 DYSGEUSIA 121 0.0016
715 SENSITIVE SKIN 12 0.0016
716 PROCEDURAL PAIN 45 0.0016
717 SPINAL PAIN 19 0.0016
718 OBSTRUCTIVE AIRWAYS DISORDER 18 0.0016
719 SENSORY LOSS 13 0.0016
720 RENAL PAIN 17 0.0016
721 BURNING SENSATION 112 0.0016
722 SKIN ULCER 41 0.0016
723 PHARYNGITIS STREPTOCOCCAL 17 0.0016
724 CHILLS 183 0.0016
725 PAIN IN JAW 44 0.0016
726 OVERDOSE 331 0.0015
727 SKIN LESION 42 0.0015
728 LIGAMENT SPRAIN 15 0.0015
729 INTERVERTEBRAL DISC PROTRUSION 33 0.0015
730 APHONIA 21 0.0015
731 NERVOUSNESS 78 0.0015
732 WHITE BLOOD CELL COUNT DECREASED 160 0.0015
733 BLOOD PRESSURE DECREASED 98 0.0015
734 BASAL CELL CARCINOMA 23 0.0015
735 MOTOR DYSFUNCTION 15 0.0015
736 FUNGAL INFECTION 49 0.0015
737 SLEEP APNOEA SYNDROME 28 0.0015
738 ABDOMINAL PAIN LOWER 37 0.0015
739 PULMONARY EMBOLISM 139 0.0015
740 DIZZINESS POSTURAL 14 0.0014
741 POOR QUALITY SLEEP 31 0.0014
742 FISTULA 16 0.0014
743 MUCOSAL INFLAMMATION 37 0.0014
744 BLOOD ALKALINE PHOSPHATASE INCREASED 35 0.0014
745 ANGIOEDEMA 62 0.0014
746 DRUG DEPENDENCE 225 0.0014
747 DERMATITIS ATOPIC 73 0.0014
748 DRY EYE 69 0.0014
749 TOOTH FRACTURE 15 0.0014
750 LUNG INFECTION 21 0.0014
751 HAEMATOMA 35 0.0013
752 ATRIAL FIBRILLATION 131 0.0013
753 MUSCLE ATROPHY 17 0.0013
754 WRIST FRACTURE 16 0.0013
755 FEEDING DISORDER 27 0.0013
756 INFLAMMATORY BOWEL DISEASE 13 0.0013
757 INJECTION SITE BRUISING 106 0.0013
758 ROTATOR CUFF SYNDROME 17 0.0013
759 ANAEMIA 252 0.0013
760 METASTASES TO LIVER 23 0.0013
761 SALIVARY HYPERSECRETION 13 0.0013
762 BONE PAIN 76 0.0013
763 FOOD ALLERGY 10 0.0013
764 CONJUNCTIVITIS 24 0.0013
765 ACNE 98 0.0013
766 INTENTIONAL PRODUCT MISUSE 113 0.0013
767 HYPERSOMNIA 37 0.0013
768 DIARRHOEA HAEMORRHAGIC 12 0.0013
769 MYALGIA 218 0.0013
770 GOUT 23 0.0013
771 BLOOD GLUCOSE FLUCTUATION 14 0.0013
772 BLOOD MAGNESIUM DECREASED 11 0.0013
773 ANGER 43 0.0013
774 HYPOTENSION 254 0.0013
775 CRYING 46 0.0013
776 OCULAR DISCOMFORT 14 0.0012
777 CHEST DISCOMFORT 126 0.0012
778 LIMB INJURY 33 0.0012
779 PULMONARY MASS 18 0.0012
780 BLOOD PRESSURE ABNORMAL 24 0.0012
781 DRUG RESISTANCE 31 0.0012
782 NEEDLE ISSUE 35 0.0012
783 MYELOSUPPRESSION 43 0.0012
784 UROSEPSIS 11 0.0012
785 DIABETES MELLITUS INADEQUATE CONTROL 21 0.0012
786 COVID-19 PNEUMONIA 14 0.0012
787 DRY THROAT 12 0.0012
788 OCULAR HYPERAEMIA 56 0.0012
789 CHOKING 23 0.0012
790 EYE PAIN 66 0.0012
791 INTESTINAL OBSTRUCTION 44 0.0012
792 SPEECH DISORDER 61 0.0012
793 SKELETAL INJURY 12 0.0012
794 MUSCLE STRAIN 10 0.0012
795 EYE INFLAMMATION 11 0.0012
796 PHOTOSENSITIVITY REACTION 19 0.0011
797 GASTROINTESTINAL INFLAMMATION 9 0.0011
798 TRANSFUSION 12 0.0011
799 DYSURIA 42 0.0011
800 PNEUMONITIS 31 0.0011
801 IMMUNE SYSTEM DISORDER 15 0.0011
802 HOT FLUSH 85 0.0011
803 MIDDLE INSOMNIA 21 0.0011
804 BRONCHOSPASM 16 0.0011
805 HEPATOMEGALY 11 0.0011
806 ABNORMAL FAECES 9 0.0011
807 DERMATITIS 23 0.0011
808 INCREASED TENDENCY TO BRUISE 10 0.0011
809 SKIN HAEMORRHAGE 16 0.0011
810 SKIN EXFOLIATION 91 0.0011
811 SNEEZING 24 0.0011
812 SWELLING FACE 69 0.0011
813 FRACTURE 20 0.0011
814 UPPER LIMB FRACTURE 21 0.0011
815 MICTURITION URGENCY 12 0.0010
816 INCREASED APPETITE 20 0.0010
817 INCONTINENCE 11 0.0010
818 VITAMIN D DEFICIENCY 10 0.0010
819 RED BLOOD CELL COUNT DECREASED 29 0.0010
820 DRUG EFFECT LESS THAN EXPECTED 15 0.0010
821 EYE PRURITUS 34 0.0010
822 SKIN DISCOLOURATION 46 0.0010
823 SOMNOLENCE 200 0.0010
824 NERVE COMPRESSION 9 0.0010
825 COMA 46 0.0010
826 PAIN OF SKIN 26 0.0010
827 GASTRIC HAEMORRHAGE 11 0.0010
828 OSTEOMYELITIS 17 0.0009
829 LYMPHADENOPATHY 33 0.0009
830 END STAGE RENAL DISEASE 17 0.0009
831 MASS 13 0.0009
832 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 51 0.0009
833 INFLUENZA LIKE ILLNESS 76 0.0009
834 MACULAR DEGENERATION 11 0.0009
835 PLATELET COUNT DECREASED 97 0.0009
836 STAPHYLOCOCCAL INFECTION 30 0.0009
837 FEMUR FRACTURE 28 0.0009
838 DENTAL CARIES 10 0.0009
839 MALIGNANT MELANOMA 12 0.0009
840 LACRIMATION INCREASED 27 0.0009
841 POST PROCEDURAL COMPLICATION 17 0.0009
842 RASH ERYTHEMATOUS 42 0.0009
843 HYPOPHAGIA 22 0.0009
844 OSTEOPENIA 13 0.0009
845 FEELING ABNORMAL 205 0.0009
846 HAEMORRHAGE 89 0.0009
847 PRODUCT DOSE OMISSION IN ERROR 24 0.0008
848 HYPERLIPIDAEMIA 10 0.0008
849 EYE SWELLING 31 0.0008
850 BONE DENSITY DECREASED 26 0.0008
851 COLITIS 31 0.0008
852 JAUNDICE 22 0.0008
853 BALANCE DISORDER 70 0.0008
854 PALLOR 22 0.0008
855 TOOTH EXTRACTION 10 0.0008
856 PRODUCT DOSE OMISSION ISSUE 234 0.0008
857 LYMPHOCYTE COUNT DECREASED 14 0.0008
858 DRUG LEVEL INCREASED 13 0.0008
859 CEREBROVASCULAR ACCIDENT 132 0.0008
860 LUNG NEOPLASM MALIGNANT 32 0.0008
861 INFUSION SITE PAIN 10 0.0008
862 THERAPY PARTIAL RESPONDER 12 0.0008
863 POLLAKIURIA 32 0.0008
864 GASTRITIS 20 0.0008
865 FLATULENCE 43 0.0008
866 PHOTOPHOBIA 14 0.0007
867 HYPERGLYCAEMIA 27 0.0007
868 INJECTION SITE PAIN 227 0.0007
869 METASTASES TO BONE 12 0.0007
870 SYNCOPE 73 0.0007
871 BLOOD GLUCOSE INCREASED 137 0.0007
872 APPLICATION SITE PAIN 16 0.0007
873 DEPRESSED MOOD 38 0.0007
874 LETHARGY 41 0.0007
875 EPISTAXIS 53 0.0007
876 HAEMATOCRIT DECREASED 14 0.0007
877 THROAT TIGHTNESS 19 0.0007
878 ANGINA PECTORIS 20 0.0007
879 DRY SKIN 93 0.0007
880 MYOCARDIAL INFARCTION 121 0.0007
881 INCORRECT DOSE ADMINISTERED 157 0.0007
882 AMENORRHOEA 12 0.0007
883 HYPOAESTHESIA ORAL 10 0.0007
884 HAEMOGLOBIN DECREASED 68 0.0007
885 DRUG EFFECT INCOMPLETE 24 0.0007
886 CONSTIPATION 144 0.0007
887 CHRONIC KIDNEY DISEASE 50 0.0007
888 SURGERY 38 0.0006
889 HYPERHIDROSIS 83 0.0006
890 PRODUCT ADMINISTRATION ERROR 13 0.0006
891 RASH MACULAR 22 0.0006
892 THROMBOSIS 50 0.0006
893 DEPENDENCE 34 0.0006
894 PRESYNCOPE 15 0.0006
895 HAEMOPTYSIS 17 0.0006
896 EYE IRRITATION 35 0.0006
897 NEUROPATHY PERIPHERAL 57 0.0006
898 BLOOD GLUCOSE ABNORMAL 11 0.0006
899 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 31 0.0006
900 SUICIDAL IDEATION 54 0.0006
901 MOOD ALTERED 16 0.0006
902 BLOOD GLUCOSE DECREASED 28 0.0006
903 INJECTION SITE HAEMORRHAGE 46 0.0006
904 URINARY INCONTINENCE 17 0.0006
905 BLOOD POTASSIUM DECREASED 17 0.0006
906 TRANSIENT ISCHAEMIC ATTACK 19 0.0006
907 AGITATION 41 0.0006
908 DYSARTHRIA 21 0.0006
909 SINUS DISORDER 11 0.0006
910 INJECTION SITE PRURITUS 37 0.0006
911 NO ADVERSE EVENT 100 0.0006
912 INJECTION SITE SWELLING 41 0.0005
913 DISEASE RECURRENCE 25 0.0005
914 NEOPLASM PROGRESSION 18 0.0005
915 INTERSTITIAL LUNG DISEASE 25 0.0005
916 HYPOGLYCAEMIA 25 0.0005
917 LIP SWELLING 17 0.0005
918 INJECTION SITE ERYTHEMA 63 0.0005
919 DIPLOPIA 13 0.0005
920 TREMOR 83 0.0005
921 VISION BLURRED 68 0.0005
922 PANIC ATTACK 18 0.0005
923 RENAL IMPAIRMENT 41 0.0005
924 INJECTION SITE MASS 18 0.0005
925 DYSPHAGIA 46 0.0005
926 CARDIAC DISORDER 45 0.0005
927 NERVOUS SYSTEM DISORDER 15 0.0005
928 MOOD SWINGS 15 0.0005
929 SEIZURE 54 0.0005
930 RESTLESSNESS 17 0.0005
931 BREAST CANCER 43 0.0005
932 RENAL FAILURE 59 0.0004
933 PRODUCT DOSE OMISSION 29 0.0004
934 CHROMATURIA 10 0.0004
935 AGEUSIA 11 0.0004
936 WITHDRAWAL SYNDROME 18 0.0004
937 UNEVALUABLE EVENT 32 0.0004
938 DEATH 363 0.0004
939 PRODUCT PRESCRIBING ERROR 10 0.0004
940 BLOOD CREATINE PHOSPHOKINASE INCREASED 12 0.0004
941 NEUTROPENIA 56 0.0004
942 OESOPHAGEAL CARCINOMA 12 0.0004
943 HIP FRACTURE 13 0.0004
944 DEHYDRATION 53 0.0004
945 HAEMATEMESIS 10 0.0004
946 SKIN IRRITATION 18 0.0004
947 PERICARDIAL EFFUSION 9 0.0004
948 EXPIRED PRODUCT ADMINISTERED 12 0.0004
949 URINARY RETENTION 12 0.0004
950 SEPSIS 40 0.0004
951 DYSKINESIA 14 0.0003
952 DEAFNESS 9 0.0003
953 APPLICATION SITE ERYTHEMA 9 0.0003
954 RENAL DISORDER 16 0.0003
955 ARRHYTHMIA 16 0.0003
956 DRUG EFFECT DECREASED 18 0.0003
957 DISORIENTATION 13 0.0003
958 BLOOD CREATININE INCREASED 21 0.0003
959 COGNITIVE DISORDER 15 0.0003
960 MENTAL DISORDER 13 0.0003
961 MALIGNANT NEOPLASM PROGRESSION 30 0.0003
962 GASTROINTESTINAL HAEMORRHAGE 24 0.0003
963 ABORTION SPONTANEOUS 11 0.0003
964 FEBRILE NEUTROPENIA 17 0.0003
965 VAGINAL HAEMORRHAGE 11 0.0003
966 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 16 0.0002
967 PULMONARY OEDEMA 10 0.0002
968 DISTURBANCE IN ATTENTION 12 0.0002
969 BLINDNESS 9 0.0002
970 SUICIDE ATTEMPT 13 0.0002
971 CARDIAC FAILURE 17 0.0002
972 EMOTIONAL DISTRESS 25 0.0002
973 TOXICITY TO VARIOUS AGENTS 34 0.0002
974 FLUSHING 19 0.0002
975 ACCIDENTAL EXPOSURE TO PRODUCT 19 0.0002
976 IRRITABILITY 11 0.0002
977 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 37 0.0002
978 HYPONATRAEMIA 10 0.0002
979 ACUTE KIDNEY INJURY 27 0.0002
980 INTENTIONAL OVERDOSE 11 0.0002
981 DRUG INTERACTION 26 0.0002
982 DEVICE MALFUNCTION 11 0.0002
983 CARDIAC FAILURE CONGESTIVE 12 0.0001
984 HALLUCINATION 11 0.0001
985 MULTIPLE SCLEROSIS RELAPSE 10 0.0001
986 SKIN BURNING SENSATION 10 0.0001
987 DEVICE DIFFICULT TO USE 9 0.0001
988 DRUG DOSE OMISSION 17 0.0001